Checkpoint Trends Limited (CHECKPOINT.BO)
INR 13.85
(-1.98%)
INR 13.85
(-1.98%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 11.3 Million INR | -2.65% |
| 2022 | 11.61 Million INR | -42.26% |
| 2021 | 20.11 Million INR | 314.82% |
| 2020 | 4.85 Million INR | -50.92% |
| 2019 | 9.88 Million INR | 67.15% |
| 2018 | 5.91 Million INR | -75.94% |
| 2017 | 24.57 Million INR | 696.18% |
| 2016 | 3.08 Million INR | 58.02% |
| 2015 | 1.95 Million INR | 0.0% |
| 2014 | - INR | 0.0% |
| 2013 | - INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 1 Million INR | -78.72% |
| 2023 Q3 | 1.7 Million INR | -41.07% |
| 2023 Q2 | 2.9 Million INR | 45.0% |
| 2023 FY | 11.3 Million INR | -2.66% |
| 2023 Q1 | 2 Million INR | 150.07% |
| 2023 Q4 | 4.7 Million INR | 175.01% |
| 2022 Q2 | 3.6 Million INR | -29.47% |
| 2022 Q3 | 2.11 Million INR | -41.28% |
| 2022 Q1 | 5.1 Million INR | -17.79% |
| 2022 FY | 11.61 Million INR | -42.26% |
| 2022 Q4 | 799.79 Thousand INR | -62.17% |
| 2021 Q2 | 2.6 Million INR | -62.65% |
| 2021 Q3 | 4.35 Million INR | 67.31% |
| 2021 Q4 | 6.2 Million INR | 42.72% |
| 2021 Q1 | 6.96 Million INR | 133.97% |
| 2021 FY | 20.11 Million INR | 314.82% |
| 2020 Q4 | 2.97 Million INR | 197.52% |
| 2020 FY | 4.85 Million INR | -50.92% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 875 Thousand INR | 0.0% |
| 2020 Q3 | 1 Million INR | 14.29% |
| 2019 Q1 | 926 Thousand INR | -69.14% |
| 2019 FY | 9.88 Million INR | 67.15% |
| 2019 Q4 | 6.3 Million INR | 404.56% |
| 2019 Q2 | 1.4 Million INR | 51.19% |
| 2019 Q3 | 1.25 Million INR | -10.71% |
| 2018 Q3 | 1.09 Million INR | 20.35% |
| 2018 Q1 | 909 Thousand INR | -73.33% |
| 2018 Q2 | 909 Thousand INR | 0.0% |
| 2018 FY | 5.91 Million INR | -75.94% |
| 2018 Q4 | 3 Million INR | 174.29% |
| 2017 Q4 | 3.4 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q1 | 9.9 Million INR | 647.73% |
| 2017 Q2 | 11.27 Million INR | 13.84% |
| 2017 FY | 24.57 Million INR | 696.18% |
| 2016 Q3 | 975 Thousand INR | 23.73% |
| 2016 Q4 | 1.32 Million INR | 35.79% |
| 2016 FY | 3.08 Million INR | 58.02% |
| 2016 Q1 | 725 Thousand INR | 4.39% |
| 2016 Q2 | 788 Thousand INR | 8.69% |
| 2015 Q3 | 647 Thousand INR | 5.72% |
| 2015 FY | 1.95 Million INR | 0.0% |
| 2015 Q2 | 612 Thousand INR | 0.0% |
| 2015 Q4 | 694.5 Thousand INR | 7.34% |
| 2015 Q1 | - INR | 0.0% |
| 2014 Q2 | - INR | 0.0% |
| 2014 FY | - INR | 0.0% |
| 2014 Q1 | - INR | 0.0% |
| 2014 Q3 | - INR | 0.0% |
| 2014 Q4 | - INR | 0.0% |
| 2013 Q4 | - INR | 0.0% |
| 2013 FY | - INR | 0.0% |
| 2013 Q2 | - INR | 0.0% |
| 2013 Q3 | - INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 2.22 Billion INR | 99.492% |
| Everest Organics Limited | 1.97 Billion INR | 99.427% |
| GUJARAT INJECT (KERALA) LTD. | 57.88 Million INR | 80.462% |
| NATURO INDIABULL LIMITED | 418.93 Million INR | 97.3% |
| NEXUS SURGICAL AND MEDICARE LI | 34.74 Million INR | 67.448% |
| Rajnish Wellness Limited | 766.84 Million INR | 98.525% |
| Rama Vision Limited | 895.7 Million INR | 98.737% |
| Vivo Bio Tech Limited | 454.51 Million INR | 97.512% |